pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·5h ago·1 min read
save

BioNTech names Sobi's Guido Oelkers as incoming CEO

BioNTech has tapped Sobi’s Guido Oelkers as its new CEO, who will start Feb. 1, 2027, at the latest. Sobi also said Monday it is on the lookout for his replacement. ...

Aug 3, 2026·read at Endpoints ↗

Guido Oelkers, BioNTech's next CEO August 3, 2026 07:07 AM EDT People BioN­Tech names So­bi's Gui­do Oelk­ers as in­com­ing CEO Anna Brown News Reporter BioN­Tech has tapped So­bi’s Gui­do Oelk­ers as its new CEO, who will start Feb. 1, 2027, at the lat­est. So­bi al­so … Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
80 words · retrieved 4h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 54m agoFDA expands Pluvicto label, making it available to most metastatic prostate cancer patientsEndpoints
  • 1h agoCurium buys radiopharma rival Lantheus for $8B; Sandoz settles price-fixing caseEndpoints
  • 2h agoWork ethic becomes a flashpoint as China's biotech pace quickensEndpoints
  • 4h agoUpdate: Supernus, Indivior to merge and form CNS-focused drugmakerEndpoints
  • 5h agoDash Bio raises $30M Series A led by Oak HC/FTEndpoints